Project Description
The Philips Nasal Alar SpO2 Sensor ensures dependable monitoring of oxygen saturation at the nasal ala, where a robust blood supply from the internal and external carotid arteries is maintained. This location generates a strong, consistent signal and is less susceptible to vascular constriction compared to extremities.
The Philips Nasal Alar SpO2 Sensor consistently provides accurate and reliable signals, even in challenging conditions. You can trust your readings even in critical situations involving low perfusion and centralization of blood flow. This sensor seamlessly integrates with your existing oximetry monitoring solutions, providing monitoring for up to 7 days with just one sensor for a single patient.
The nasal alar sensor provides reliable SpO₂ monitoring across care settings. In critical care, it maintains a stable signal even in hemodynamically unstable patients, reducing time spent finding perfused sites. During surgery, it responds quickly to oxygen saturation changes and can remain in place through transitions from the OR to PACU, ICU, and beyond. In acute care, it keeps patients’ hands free, is easy to apply and rotate, and supports hygiene while reducing infection risk.
Accurate and reliable signal
Comfortable and durable with expected service life of up to 7 days
Good signal quality even in patients with poor perfusion
Patient’s hands are sensor-free
Easy sensor accessibility when used in the OR
One sensor can be used on the patient for an extended stay up to seven days
One size fits all patients ≥15 kg minimum age of 4 years
Adhesive-free
Lower occurrence of pressure injury than with forehead sensors



